𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitors of acyl-coa:cholesterol acyltransferase (ACAT). 15. sulfonylurea inhibitors with excellent hypocholesterolemic activity in vivo.

✍ Scribed by Bruce D. Roth; W. Howard Roark; Joseph A. Picard; Richard L. Stanfield; Richard F. Bousley; Maureen K. Anderson; Katherine L. Hamelehle; Reynold Homan; Brian R. Krause


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
206 KB
Volume
5
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

✦ Synopsis


A series of sulfonylureas were prepared and tested for the ability to inhibit the enzyme acyl-CoA: cholesterol acyltransferase (ACAT) in vitro and lower plasma cholesterol in cholesterol-fed rats in vivo. Although compounds from this series were generally weak inhibitors of ACAT in vitro, several displayed excellent hypocholesterolemic activity in vivo.


πŸ“œ SIMILAR VOLUMES


Inhibitors of acyl-CoA: Cholesterol O-ac
✍ Patrick M. O'Brien; Drago R. Sliskovic; Adele Bernabei; Timothy Hurley; Maureen πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier Science 🌐 English βš– 274 KB

The syntheses and biological activities for anilides derived from 2-phenyl-2-(dodecyl-2H-tetrazol-5-yl)acetic acid are described. Evidence is provided that one of these compounds, (+)-8b, stereoselectively inhibits ACAT in vitro and possesses superior efficacy in vivo compared to (-)-8b or the racem

Inhibitors of acyl-CoA: cholesterol O-ac
✍ D.R. Sliskovic; J.A. Picard; W.H. Roark; A.D. Essenburg; B.R. Krause; L.L. Minto πŸ“‚ Article πŸ“… 1996 πŸ› Elsevier Science 🌐 English βš– 332 KB

The synthesis and structure-activity relationships of a series of malonester amide ACAT inhibitors are described. One of these compounds, 4s, was shown to be a potent inhibitor of both the intestinal and arterial enzymes, bioactive upon oral dosing (ex vivo bioassay) and efficacious in a clinically